In patients with BMI <30 but with obesity-related comorbidities (e.g., OSA, prediabetes, NAFLD), how comfortable are you initiating GLP-1s?

In patients with BMI <30 but with obesity-related comorbidities (e.g., OSA, prediabetes, NAFLD), how comfortable are you initiating GLP-1s?

• Very comfortable, it is apart of my daily practice
• Comfortable, but I explore other options before prescribing GLP1-agonists
• Comfortable, but the prior authorization process turns me off to using them more
• Not comfortable, I do not tend to use them for these indications
• Other